Incyte | INCY - EPS ربحية السهم


Fiscal التقويم فعلي إجماع السابق تاريخ
FY2026Q3 Sep/2026 -3.60 1.98 2.26 Oct/29
FY2026Q2 Jun/2026 3.09 1.99 1.57 Jul/28
FY2026Q1 Mar/2026 1.81 1.42 1.16 Apr/28
FY2025Q4 Dec/2025 1.80 1.93 1.43 Feb/10
FY2025Q3 Sep/2025 2.26 1.58 1.07 Oct/28




Eps تغيير تاريخ
Acadia Pharmaceuticals USD 0.31 0.13 2026-09
Agenus USD 1.02 1.32 2026-03
Agios Pharmaceuticals USD -1.09 0.6 2026-09
Alnylam Pharmaceuticals USD 16.26 14.42 2026-09
Amgen USD 6.45 0.16 2026-09
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
Biogen USD 2.62 0.98 2026-09
BioMarin Pharmaceutical USD 0.23 0.97 2026-09
Bristol-Myers Squibb USD 1.35 0.69 2026-09
Eli Lilly USD 7.48 0.9 2026-09
Exelixis USD 0.94 0.03 2026-09
Gilead Sciences USD 2.55 9.3 2026-09
Incyte USD -3.6 6.69 2026-09
Ionis Pharmaceuticals USD 0.66 1.35 2026-09
MacroGenics USD 0.31 0.89 2026-06
Merck USD 2.49 2.62 2026-09
Moderna USD 0.38 2.35 2026-09
Nektar Therapeutics USD -1.78 0.43 2026-03
Neurocrine Biosciences USD 3.29 0.44 2026-09
Novartis USD 2.46 0.05 2026-09
Novartis USD 0.63 1.36 2026-09
Pfizer USD 0.87 0.1 2026-09
PTC Therapeutics USD -0.62 1.54 2026-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 20.07 5.78 2026-09
Sarepta Therapeutics USD 0.13 0.51 2026-09
Ultragenyx Pharmaceutical USD -1.16 0.26 2026-09
Vertex Pharmaceuticals USD 4.76 0.03 2026-09